SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 24.56% in the revenue at Rs. 1736.10 millions was reported in the March 2025 quarter as compared to Rs. 1393.80 millions during year-ago period.The Company has registered profit of Rs. 865.00  millions for the quarter ended March 2025, a growth of 23.78%  over Rs. 698.80 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2025 rose to 1162.90 millions as compared to 938.60 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1736.10 1393.80 24.56 7524.10 6250.90 20.37 7524.10 6250.90 20.37
Other Income 412.50 361.80 14.01 1345.90 1058.40 27.16 1345.90 1058.40 27.16
PBIDT 1162.90 938.60 23.90 4665.60 3929.20 18.74 4665.60 3929.20 18.74
Interest 0.40 0.20 100.00 1.20 1.00 20.00 1.20 1.00 20.00
PBDT 1162.50 938.40 23.88 4664.40 3928.20 18.74 4664.40 3928.20 18.74
Depreciation 60.90 69.30 -12.12 247.70 270.80 -8.53 247.70 270.80 -8.53
PBT 1101.60 869.10 26.75 4416.70 3657.40 20.76 4416.70 3657.40 20.76
TAX 236.60 170.30 38.93 1021.80 820.30 24.56 1021.80 820.30 24.56
Deferred Tax 0.30 -1.90 -115.79 -7.20 -40.90 -82.40 -7.20 -40.90 -82.40
PAT 865.00 698.80 23.78 3394.90 2837.10 19.66 3394.90 2837.10 19.66
Equity 152.00 151.90 0.07 152.00 151.90 0.07 152.00 151.90 0.07
PBIDTM(%) 66.98 67.34 -0.53 62.01 62.86 -1.35 62.01 62.86 -1.35

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×